The task of defining schizophrenia pathogenesis has fascinated and frustrated researchers for nearly a century. In recent years, unprecedented advances from diverse fields of study have given credence to both viral and developmental theories. This review considers possible mechanisms by which viral and developmental processes may interact to engender schizophrenia. Many of the current controversies in schizophrenia pathogenesis are reviewed in light of the viral hypothesis, including: epidemiological findings and the role of a genetic diathesis, phenotype heterogeneity, abnormalities in excitatory and inhibitory neurotransmitter systems, anomalous cerebral latereralization, and static vs progressive disease. The importance of animal models in elucidating the impact of viral infections on developing neurons is illustrated by recent studies in which neonatal rats are infected with lymphocytic choriomeningitis virus in order to examine alterations in hippocampal circuitry. Finally, consideration is given to a new hypothesis that some cases of schizophrenia could be instigated by a viral infection that disrupts developing inhibitory circuits, consequently unleashing glutamatergic neurotransmission leading to selective excitotoxicity, and a degenerative disease course. Molecular Psychiatry (2001) 6, 634-646.
Although the last three decades have brought tremendous progress in the diagnosis, classification and treatment of schizophrenia, the etiology of the disease remains unknown. In recent years, evidence has accumulated supporting both neurodevelopmental and viral models of schizophrenia. The goal of this review is to elucidate the points at which neurodevelopmental and viral mechanisms intersect, with particular focus on pathophysiological processes that can be examined on a cellular and molecular level.
Human and epidemiological studies
The neurodevelopmental hypothesis of schizophrenia has been cogently argued and is supported by several converging lines of evidence derived from studies in neuropsychology, developmental biology, and pathology. [1] [2] [3] [4] Neuropsychological studies have shown that while schizophrenia is not typically manifested clinically until late adolescence, behavioral and motor signs of risk are observed much earlier indicating the existence of an insidious brain disorder that precedes psychotic symptoms. 1 Minor physical malformations such as craniofacial asymmetries or dermatoglyphic irregularities are also increased in patients with schizophrenia suggesting an association with aberrant morphogenesis. 5, 6 These physical abnormalities occurring outside the brain are considered nonspecific indicators of schizophrenia and are not thought to be involved in disease causation; however, from the perspective of a viral etiology this apparently reasonable assumption cannot be taken for granted because subtle defects in peripheral development could include immune tissues (eg, tonsillar lymphatics, thymus) and thus alter viral susceptibility or immune responses.
Cytoarchitectural studies also support the neurodevelopmental hypothesis, and suggest that disruption of neuronal circuits during development is an important antecedent to schizophrenia. [2] [3] [4] 7 Autopsy studies of schizophrenic brains have found evidence of disturbed neuronal formation and migration, [8] [9] [10] abnormal expression of developmentally-regulated molecules such as NCAM, 11 and a lack of gliosis in brain regions exhibiting cell loss. 7, 12 Of note, abnormal levels of an NCAM isoform have been found in the CSF of schizophrenia patients. 13, 14 This abnormality did not appear to be linked to antipsychotic medication, 14 and because monozygotic twin pairs discordant for schizophrenia were likewise discordant for these CSF NCAM elevations, an environmental insult during neurodevelop-ment could have triggered persistent alterations in this developmentally-regulated molecule. 13 Current neurodevelopmental theories of schizophrenia posit that both genetic and environmental factors contribute to aberrant brain maturation. 3, [15] [16] [17] The essential role of environmental factors has been unequivocally demonstrated in studies of concordance rates for schizophrenia in monozygotic twins. Most well-controlled studies have yielded concordance rates of less than 50% (compared to a theoretical value of 100% if the schizophrenia was purely genetic). 18, 19 The ability of environmental factors to affect temporal-limbic structures such as the hippocampus is underscored by a recent study of monozygotic twins who were discordant for schizophrenia; hippocampal volumes were consistently reduced only in the afflicted members of the pairs. 20 Nevertheless, twin studies also argue for genetic determinants since concordance rates are much higher for monozygotic than dizygotic twins. 18, 19 Even so, such data may be skewed by environmental factors because monozygotic twin pairs are in theory more likely to be co-exposed to the same sets of pathogens during neurodevelopment. Studies pertaining to the intrauterine environment of twins are informative in this regard. Monozygotic twins can either share the same placenta, in which case they are termed 'monochorionic', or each twin can have its own placenta (and thus its own blood circulation) in which case the pairs are termed 'dichorionic'. 21 Concordance rates for schizophrenia are higher for monochorionic vs dichorionic twins. 22 Since in either case the twin pairs begin with essentially the same genome, the higher incidence of schizophrenia in monochorionic twins is a function of their shared placenta, and is consistent with the idea that a virus or other pathogen causes schizophrenia by infecting the placenta and invading the enveloped fetus(es). 23 These data, along with the established ability of teratogenic viruses to affect one or both members of a twin pair, 24 are consistent with epidemiological studies of twins, and give the viral hypothesis of schizophrenia an advantage over environmental mechanisms invoking the concept of a freely-diffusible maternal factor or toxin (which would be expected to affect monochorionic and dichorionic twins equally).
The observed discordance rates for twins could also be explained within the framework of a virus-triggered autoimmune reaction because monozygotic twins have different T-cell repertoires, and thus a virus could infect both twins equally but the immune response could be the essential determinant of disease expression. 23 Indeed, this is one of many post-zygotic genetic events which could be invoked to explain discordance for schizophrenia between identical twins. 25 In addition, it is conceivable that schizophrenia could be a disorder which, like Alzheimer's disease, has purely genetic subtypes as well as 'sporadic' forms which arise due to environmental agents acting on genetically susceptible individuals. Nonetheless, no gene or set of genes has been consistently and reproducibly linked to schizophrenia. 16, 26 Although the putative environmental agent responMolecular Psychiatry sible for the initial neurodevelopmental insult in schizophrenia has not been discovered, prenatal or neonatal viral infections deserve prominent consideration based on epidemiological, immunological and neuropathological studies. Such foundations for the viral hypothesis have been reviewed extensively, 23, [27] [28] [29] [30] and despite an abundance of negative studies, new data continue to emerge linking viral infections to the etiopathogenesis of schizophrenia. [31] [32] [33] [34] [35] [36] [37] [38] Agents which have recently been associated with schizophrenia include rubella, 31 which has long been known to infect the human CNS, and Borna disease virus, which has only recently been demonstrated to infect humans. [39] [40] [41] [42] The ability of Borna virus to infect limbic structures adds further to the interest in this agent as a possible cause of schizophrenia and other neuropsychiatric disorders. 43 Paradigms of viral pathogenesis during neurodevelopment Viruses are ubiquitous human pathogens with well established teratogenic effects on the CNS. 44 While some studies showing an association between viruses and schizophrenia have focused on specific pathogens (ie antibody studies of herpes simplex virus or epidemiological associations between schizophrenia and in utero exposure to influenza) other studies have provided more indirect support for a viral etiology. For example, household crowding and the likelihood of being born in the winter or spring are increased among people who eventually develop schizophrenia, consistent with a heightened exposure to viruses under these conditions. 45 Similarly, a recent report suggests that schizophrenia patients were less likely than the control population to be breastfed as infants, raising the possibility that these patients were deprived of protective maternal antibodies in breast milk. 46 Nevertheless, no single risk factor points definitively to a viral etiology. This may reflect the complexity of the environmental and genetic interactions required to give rise to schizophrenia. As will be discussed in more detail later, viral and genetic etiologies for schizophrenia are conceptually complementary because host genes determine individual susceptibilities and immune responses to viral infections, and thus genetic variables help control disease diathesis following viral exposure. 47 Despite numerous well performed studies linking congenital or neonatal viral infections to schizophrenia, the viral hypothesis remains compelling but is as yet unproven. Perhaps most vexing to both critics and proponents of the viral hypotheses is the variability between studies (particularly serological analysis) and the failure to identify a specific virus as being consistently associated with all or most cases of the disease. 28, 30, 48 Thus, there is a need to refine the paradigms that are used to interpret available data and guide future studies of schizophrenia pathogenesis. These paradigms should be designed with the recognition that schizophrenia is a heterogeneous disease, and clinical subtypes of the disease may be reflections of sub-mechanisms of pathogenesis. [49] [50] [51] [52] The first step in refining these paradigms of pathogenesis is to ask what type of data can be reasonably expected if viruses are involved in the etiology of schizophrenia. The human host is constantly confronted with emerging and undefined viral pathogens. Many viral infections do not come to clinical attention even when they occur during pregnancy, and only in rare cases involving severe symptoms or clear diagnostic signs is the responsible virus isolated or identified. 44, 53, 54 The fetus is vulnerable to ascending infections of the genital tract (particularly if fetal membranes ruptured), as well as viruses that cross the placenta. 44, 53 Once the fetus becomes infected, its immature blood-brain barrier may not offer adequate defense against viral invasion or pernicious immune molecules. 55 In the case of schizophrenia, the established hallmarks of a viral infection, such as inclusion bodies or viral antigens may be undetectable at autopsy because the infection could insidiously disrupt development and then be cleared from the brain prior to the manifestation of symptoms decades later. 28 Antibody serology might also fail to detect past evidence of the infection because immunoglobulin production develops slowly during gestation and remains impaired even at birth. For example, 20-50% of neonates congenitally-infected with CMV are negative for virus-specific IgM, an important indicator of primary infection. 56 In addition, the hunt for viruses putatively responsible for schizophrenia is constrained by available reagents-the development of which usually entails the prerequisite isolation of the organism, production of an antigen/antibody, or knowledge of viral nucleic acid sequence.
Thus past difficulties in identifying a specific virus as causing schizophrenia do not invalidate the viral hypothesis for the disease. In fact, it may be naive to expect that a specific virus will ever be found to be responsible for all cases of schizophrenia. In this regard, established viral diseases of the CNS are instructive: paralytic poliomyelitis is a quintessential virus-induced neurological disease clearly caused by a specific virus (poliovirus). Nevertheless, prior to widespread vaccination against poliovirus, a small portion of the cases were found to be caused by viruses other than poliovirus, 57 and in 37% of cases, attempts to isolate any causative virus during the acute phase of the disease were unsuccessful. 58 Thus it is not surprising that attempts to isolate poliovirus from CSF a decade or more after the initial infection (as would likely be the case in schizophrenia) failed to yield infectious virus. 59 Similarly, highly sensitive RT-PCR could not detect traces of poliovirus nucleic acids; and even in patients with recrudescent disease (postpolio syndrome), RT-PCR was positive for poliovirus genomic sequences in only 10-45% of the cases. 59, 60 Furthermore, CSF from some patients with postpolio syndrome has been found to contain genomic material from non-polio enteroviruses. 59 Indeed, while the dramatic decline in poliomyelitis following the introduction of poliovirus vaccines substantiates the causal link with this particular enterovirus, persistence of poliomyelitis in regions where poliovirus has been eliminated reveals the capacity of other viruses to cause the disease, 57 thus challenging the assumption that a viral disease must necessarily be linked to one specific virus. Moreover, some neurological disorders appear to have both viral and non viral causes. For example, Guillain-Barre can apparently be triggered by both viral and bacterial infections, 61 and in some cases noninfectious stimuli are most likely responsible. 62 Thus, schizophrenia may be caused by several different viruses which are rarely or inconsistently detected in the disease because of technical limitations, viral clearance, or multiple disease pathways.
Admittedly, an argument that schizophrenia is caused by an unidentified virus or viruses is heuristically unsatisfactory and does not explain several positive studies such as those finding increased antibodies for viruses such as HSV, CMV, influenza A, and LDH virus. 28, 30 Besides contagion differences associated with 'downward' socioeconomic drift, a number of possible explanations for these positive data can be considered. Evidence of infection with these viruses could be risk indicators; that is, merely markers of an enhanced vulnerability to viral infections. The specific causative virus may be unidentified because tests for its presence are unavailable or its feto-pathogenic potential is not yet recognized. Conversely, these infections could be indicators of increased exposure to multiple pathogens including the responsible virus. A variety of circumstances leading to increased susceptibility of a fetus to infections have been frequently considered but are difficult to study. These include maternal famine and infection with other viruses such as influenza. Epidemiological studies have found both of these to be potential precursors of schizophrenia. 33, 63 Perinatal or obstetric complications, which have been linked epidemiologically to schizophrenia, 64 could likewise be risk indicators of viral infections because abrasions or placement of fetal monitors during parturition can create a portal of entry for infections, and (like prenatal births) obstetric complications can increase perinatal exposure to nosocomial viruses. 65, 66 Viral infections and autoimmunity An alternative explanation for the finding of increased antibody titers in schizophrenia is that these patients are predisposed toward more vigorous B-cell responses, and consequently prone to develop autoantibodies. Studies of lymphocyte subsets in schizophrenia patients have found an increase in B cells, 67 as well as a subset of patients who have elevated CD5+ B cells, 68, 69 a cell type thought to be involved in autoantibody production. 70 Nevertheless, these data have not been consistently replicated, and there is even evidence of impaired immune responses in schizophrenia. 28, 30 Controversy also surrounds data from various laboratories demonstrating autoantibodies against brain constituents of schizophrenia patients. 28, 30, 71, 72 Numerous brain regions have been implicated as targets of autoimmunity. In a recent study, anti-hippocampal antibodies were found to correlate with low IL-2 responses suggesting an autoimmune phenotype in a subgroup of schizophrenia patients. 73 Exposure to a virus or class of viruses could elicit an autoimmune reaction through several possible mechanisms including molecular mimicry in which homology between a pathogen and host protein provokes autoreactive antibodies. 74 In such a case the relative refractoriness of the normal fetal immune system could serve a protective role by preventing the elaboration of potentially autoimmune antibodies or lymphocytes during the period when the blood-brain barrier (BBB) was incomplete. A critical role for the BBB in schizophrenia must be considered because this structure sequesters the CNS from invading pathogens as well as deleterious components of the immune response, 75 and individual differences in BBB development are presumably determined by genetic, as well as maternal factors such as intrauterine hypoxia. 76 Functionally, the BBB is a complex structure comprised of multiple cell types, and its ability to exclude infectious agents and pernicious immune influences is poorly understood. 75 A delay in a crucial aspect of BBB development could leave the immature brain vulnerable to a group of pathogens having the capacity to provoke a common cassette of host responses such as the elaboration of proinflammatory cytokines. These host molecules might disrupt neurodevelopment only in fetal brains unshielded by the BBB, thus leading to preschizophrenic neuro-circuitry alterations. Interestingly, a substantial portion (7-33%) of schizophrenia patients have evidence of BBB abnormalities. 28, 30 These alterations do not appear to be a consequence of antipsychotic medication. 77, 78 Nonetheless, according to neurodevelopmental theories, a defect in the BBB would be expected to precede schizophrenia. Since there are likely multiple pathophysiological routes leading to BBB impairment, the minority of patients actively manifesting BBB abnormalities after diagnosis may have succumbed to one of the pathways in which the developmental abnormality persists into adulthood. Like many putative developmental antecedents of schizophrenia, early defects in the BBB are difficult to study in humans but remain important because they could represent a crucial inherent component in the multi-factorial genetic: environmental model of schizophrenia.
The autoimmune hypothesis for schizophrenia is not limited to autoantibody formation or cytokines crossing the BBB. And while the myriad studies showing immunological alterations in schizophrenia are beyond the scope of this review, 28, 30, 48, 71 much of these data serve to demonstrate the potential importance of host responses to pathogens in determining disease expression. There is increasing evidence that viruses or other infections are capable of triggering or promoting autoimmune diseases of the nervous system; perhaps after a long latency in some instances. 79 Current theories hold that immunogenetic factors play a role in determining which infected individuals succumb to virus-elicited autoimmune disease. For example, only a small portion of people infected with HTLV-I develop Molecular Psychiatry tropical spastic paraparesis (HTLV-I associated myelopathy) but the risk of this latent complication is correlated with specific host HLA haplotypes. 80, 81 Associations between HLA types and schizophrenia (or subtypes of the disease) have also been reported, 28, 30, 71, 82 and these findings could be relevant to viral infections in utero because expression of major histocompatability genes is evident by the beginning of the second trimester. 83, 84 Thus schizophrenia could be initiated by an endemic virus that causes neuropsychiatric sequelae only in individuals who are genetically predisposed to mount an atypical immune response during a critical neurodevelopmental period. In this regard, cytokines and growth factors could be critical intermediates in this process at various stages of disease development. 85, 86 Taking this point into consideration, studies of genes controlling host susceptibility and responses to viral infections are important future directions in elucidating viral mechanisms of schizophrenia. Indeed, the immune response to a virus represents a classic example of the interaction between genetic and environmental factors. The importance of the environmental component in this interaction cannot be underestimated, and by examining patients with chronic schizophrenia (as has been the case with most immunological studies), results are confounded by exposure to antipsychotic medications, and by various socioeconomic and behavioral factors.
Constraints on human studies
A formidable obstacle to establishing a causal relationship between viral infections and the immune abnormalities in schizophrenia is the latency between the putative infection and psychiatric diagnosis. An improved approach is to study patients during their first psychotic episode, or to concentrate on children manifesting schizotypal symptoms or motor abnormalities thought to presage the disease. Even in these cases however, there is an uncertain relationship between the immune abnormalities detected, and the fetal or neonatal immune response to a virus. Analogous caveats apply to neuro-imaging studies, which typically take a macroscopic 'snapshot' of the brain during chronic disease. While there is a recognized need for longitudinal neuromorphometric studies of children and adolescents at risk for schizophrenia, ethical considerations limit the types of neuroradiologic data which can be obtained from this pre-adult population that is not actively manifesting a serious psychiatric disorder. And despite the instrumental role of neuropathological and neurochemical studies in refocusing schizophrenia research on brain mechanisms, human postmortem studies characterize predominately end-stage disease, and hence cannot untangle the interwoven succession of events occurring upon a viral or bacterial infection of the developing brain.
Furthermore, because of the complex interrelationships between a virus and its host, the identification of a particular virus as being associated with a given neurological disease is only the first step in under-standing the relevant neuropathogenic mechanisms. This concept has been most recently exemplified in HIV encephalitis whereby a retrovirus impairs brain function by indirect and largely undefined mechanisms. 87 Thus human investigations are constrained on several fronts, and animal models are needed to elucidate the cellular and molecular mechanisms by which a viral infection of a fetus or neonate can lead to structural or functional disruption of critical brain regions involved in schizophrenia.
Modeling mechanisms: defining the questions
Even the best animal model of schizophrenia cannot be expected to mimic all the heterogeneous behavioral and neuroanatomical features of the disease; if such a model existed it would likely be fraught with many of the inconsistencies and difficulties which impede the research of schizophrenia itself. Furthermore, because of the specificity of virus-host interactions, nearly all existing animal models of human viral diseases fall short of recapitulating the human condition. Similar confounds apply to the differences between humans and experimental animals in the timing of key neurodevelopmental events, including neuronal birth, migration, and synaptogensis. Moreover, because most viral theories of schizophrenia posit involvement of the immune system, disparities between species in immune responses must also be considered, particularly with regard to immune tolerance which has obvious implications for the neurodevelopmental interactions. Despite these caveats, animal models have been immeasurably useful in deciphering the neuropathogenesis of human viral infections including those causing acute and subacute encephalitis. 57 Animal models are particularly powerful tools for exploring the neurodevelopmental-viral hypothesis of schizophrenia because experimental infections permit a multi-faceted examination of each step in the succession of neuropathological events unfolding in the maturing brain, starting with the initial infection and culminating in the behavioral outcome. There are a large number of diverse viruses that are currently being examined in experimental animals, and many of these could hold clues to schizophrenia pathophysiology. Still, considering the manifold types of data which can be collected from neurovirological experiments in animals, it is important to delineate specific areas of inquiry within the schizophrenia literature so as to guide animal studies toward the goal of elucidating schizophrenia pathogenesis. These include the following:
Host susceptibility and neuroanatomical specificity On a organismal level, susceptibility can be conceptualized as the capacity of a host to support infection by a virus-this is often intimately related to the character and amplitude of the host responses as has already been discussed. Equally germane to schizophrenia, however, is susceptibility on a micro-neuroanatomical level; this is expressed as the selective vulnerability or infectability of specific neural cell types or even subsets of neurons within the host brain. 57 Although schizophrenia is not characterized by conspicuous pathology in a distinct brain region (eg like Parkinson's disease), there is considerable evidence that select sets of neurons in a limited number of brain subregions appear to be involved in the disease. A confluence of data from histopathological, neurochemical, in vivo imaging, and neuropsychological studies point to abnormalities of neuronal circuitry in corticolimbic regions particularly the prefrontal and cingulate cortices, and structures of the temporal lobe including the hippocampal formation. [88] [89] [90] [91] Despite several compelling and interesting theories, the precise nature of these circuitry abnormalities is unknown, and further progress has been hampered by inconsistencies and poor replication of the findings. These problems are due in part to methodological issues and inadequate sample availability, but more importantly they bespeak the heterogeneity of the disease. Subtypes of schizophrenia could be the result of insults occurring at different times in neurodevelopment, and thus affecting different neural circuits.
Because brain development is a dynamic process involving interacting and interdependent neuronal elements, extrapolation of human data is an ineffective means to determine the brain region(s) in which the original ontogenetic abnormality occurred. Animal models using viral infections precisely timed to specific periods of neurodevelopment have the potential to reveal specific interconnected sets of vulnerable neurons, and perhaps provide clues to disentangling the pathophysiological underpinnings of schizophrenia subtypes. Indeed, one of the strengths of the viral hypothesis for schizophrenia is the well known ability of viruses to target specific types of neurons in the CNS. 57 The consequence of viral infection on neuronal survival is of critical importance to the viral theory of schizophrenia. Fortunately, there is a growing interest in examining the mechanisms by which viruses destroy or compromise neurons (as evidenced by a recent book dedicated to this issue). 92 This cellselectivity is a function of viral and host variables. Slight changes in viral proteins within strains of the same virus can drastically alter the neuron types affected and the disease outcome. 93 Conversely, interdependent host factors such as the developmental stage at infection, expression of viral entry receptors, and immune responses determine the cell types infected and the ultimate pathology engendered by the virus. 57 An example of such pathology is aberrant neuronal migration, which has been demonstrated in experimental hosts after prenatal or neonatal infection with influenza virus, 94, 95 murine cytomegalovirus, 96 mumps virus 97 and parvovirus. 98 The mechanisms by which some viruses interfere with the cellular machinery governing neuronal migration has not been well characterized and is highly amenable to study in animal models. For example, studies in mice suggest that influenza may disrupt corticohippocampal neuronal migration by suppressing the production of reelin. 95 Abnormali-ties of neuronal migration represent a cornerstone of the neurodevelopmental hypothesis, and considering that reelin mRNA appears to be decreased in brains of schizophrenia patients, 99 the finding in influenzainfected mice underscores the potential of model systems in providing clues to pathophysiological mechanisms.
Abnormalities in neurotransmitter systems
Understandably, the belief that brain neurotransmitter abnormalities are involved in the etiopathogenesis of schizophrenia is well ensconced among psychiatric researchers and clinicians. Although this belief finds support in neurochemical studies and a massive literature in pre-clinical and clinical psychopharmacology, 89 ,100,101 a unifying hypothesis linking neurotransmitter abnormalities with neurodevelopmental insults and the neuropsychological manifestations of schizophrenia has not been forthcoming, particularly with regard to the role of virus infections.
The idea that viruses can influence neurotransmission is not in question. Beginning with the seminal work of Lycke and Roos, 102 experimental infections with an array of viruses have been shown to alter CNS monoamine systems in various and complex ways. 103, 104 This concept was demonstrated recently for Borna disease virus. Neonatal infection of rats led to learning deficiencies and changes in emotional behavior 105 with typical expression of antigens in hippocampal neurons. 43 Adult rats, originally infected as neonates, manifested increased 5-HT and NE levels in the frontal cortex. 106 Dopamine did not appear to be altered, though infection of more mature rats (eg 1 month old) has been demonstrated to increase the concentration of DOPAC, the primary metabolite of dopamine, despite minimal changes in dopamine itself. 107 While the failure to find an unambiguous increase in dopamine may appear to be a weakness of these models (given the dopamine hypothesis which invokes enhanced dopaminergic neurotransmission in schizophrenia), the task of understanding how viruses could disrupt developing neurotransmitter systems and lead to schizophrenia cannot be expected to outpace current understanding of the disease's neurochemical foundations. For example, many of the reported indicators of dopaminergic abnormalities in schizophrenia may well be attributed to antipsychotic medications. 89 Hence, despite the indubitable importance of dopaminergic systems in the psychopharmacology of schizophrenia, 101, 108 it is becoming increasingly apparent that the dopamine hypothesis cannot alone provide an adequate pathophysiological basis for either the symptomatic features or the structural and neurochemical findings in the disease. 89, 100 Consequently, there has been a resurgence of interest in the role of other neurotransmitter systems, particularly the primary inhibitory (GABA) and excitatory (glutamate) amino acid transmitters in the brain.
Examination of brain regions implicated in schizophrenia has revealed a reduction of GABAergic axon terminals in the hippocampus 109, 110 as well as the temMolecular Psychiatry poral 110 and prefrontal cortex. 111 Neurochemical and in situ hybridization studies in the frontal and temporal cortex indicate that the enzyme responsible for synthesizing GABA, GAD, is also reduced in schizophrenia. 112, 113 Synaptosomal release of GABA is likewise thought to be impaired, 112 and GABA itself may be reduced in some brain regions of patients with schizophrenia. 114, 115 The decrement of GABA is ostensibly accompanied by a compensatory upregulation of GABA-A receptors. 91 Benes at al have reported a loss of inhibitory interneurons in cingulate and prefrontal cortices, 116 and a decrease in nonpyramidal (presumably inhibitory) neurons in the hippocampus. 117 Similarly, several populations of peptidergic interneurons (which are predominately inhibitory) appear to be impaired in temporal and frontal cortices, hippocampus, or in other limbic structures. [118] [119] [120] [121] [122] [123] Although some of the foregoing studies have not been replicated or have produced inconsistent results, 110, 124 the bulk of the evidence indicates that several types of local inhibitory neurotransmitter circuits are hypofunctional in corticohippocampal brain regions of schizophrenia patients. 91, 100 Investigations of excitatory neurotransmitters in schizophrenia have produced a confusing and discrepant body of data. A decrement in glutamatergic function is implied by the finding that glutamate levels are decreased in the hippocampus, prefrontal cortex and CSF, 125, 126 but these studies have not been consistently replicated, and there may be increased levels of glutamate in some brain regions. 100, 115 Postmortem studies demonstrating a relative decrease of hippocampal complexin II (thought to be a presynaptic marker for excitatory terminals), argue that glutamatergic synapses are impoverished in the disease. 127 This decrement, however, may not be uniformly expressed because the opposite is suggested by increased levels of glutamate reuptake sites in frontal and cingulate cortex, 124, 128 and an elevated density of glutamatergic fibers in the anterior cingulate. 129 These discrepant neurochemical findings have not been clarified by analysis of excitatory amino acid (EAA) receptors in various brain regions thought to be affected in schizophrenia. Despite technical advances in analyzing NMDA and non-NMDA receptors, and the recent discovery of G-protein-linked metabotropic glutamate receptors, a consistent pattern of EAA receptor abnormalities has not been discernible in the disease. 130, 131 The hope is that with more refined cytoarchitectural mapping of glutamate subunits, and a broader understanding of interactions between excitatory and monoamine neurotransmitter systems, a compelling pathophysiological mechanism will eventually emerge. 91, 101, [130] [131] [132] Along these lines, Olney and colleagues have eloquently presented a case for hypofunctional NMDA receptors in schizophrenia, 133 though validation of this hypothesis awaits further experimentation.
Thus far, there has been a paucity of theories to describe how defects in excitatory and inhibitory neurotransmitters arise in the context of a neurodevelop-mental insult. Slowly however, a set of testable hypotheses is beginning to coalesce from the available studies. One appealing mechanism proposes that certain GABAergic interneurons are lost early in the disease during fetal or neonatal development, and that the resulting disinhibition of corticolimbic circuitry lies dormant until triggered by the maturation of these circuits during adolescence. 91 Ironically, a decrement in the function of the excitatory NMDA receptor is compatible with a loss of GABAergic inhibition because the NMDA receptor is thought to be an important positive regulator of GABA release, and thus one consequence of dysfunctional NMDA receptors in schizophrenia would be a loss of GABAergic inhibition. 91, 133 Such a mechanism could even help explain PCP-induced psychosis since NMDA antagonism can apparently cause disinhibition in the hippocampus 101 -a structure which is both important to schizophrenia and also must maintain a critical balance in excitatory and inhibitory circuits.
Nevertheless, the question remains: how can a virus during neurodevelopment result in alterations of inhibitory or excitatory neurotransmitter systems in the adult? This question can be addressed using animal models, as will be discussed later.
Anomalous cerebral lateralization
A large body of evidence supports the notion that schizophrenia is associated with structural and functional abnormalities in cerebral lateralization. [134] [135] [136] Neuroanatomical studies have found differences between schizophrenia patients and controls in the number, density or distribution of neurons between the left and right hemispheres. 8, 137, 138 Abnormalities of laterality have also been revealed by brain imaging studies measuring subregional tissue volume, blood flow, and metabolism. [139] [140] [141] [142] The hippocampus and other temporal lobe structures appear to be prominently affected. There is an unclear relationship between these structural abnormalities, and the behavioral asymmetries in schizophrenia which are purportedly manifested in motor, sensory, language and cognitive function. 134, 135 The idea that these lateralization abnormalities arise during development is gaining support, but little attention has been given to the possible involvement of a viral infection.
Viruses could cause disturbances in the laterality of brain development through several mechanisms. Many viruses can invade the CNS from a peripheral portal of entry by tracking along nerve fibers and entering only one side of the brain. 57 While this process has been well studied in adult animals, there are scant data as how such infections might affect brain lateralization during development. Another way in which viruses could influence cerebral lateralization is through their effects on the immune system. Studies of mouse models indicate that autoimmunity and the maternal or fetal immune status are potentially important determinants of lateralization differences during neurodevelopment. 134 Conversely, cerebral asymmetries influence immune responses. 143 Therefore it is conceivable that abnormalities in lateralization during neurodevelopment, whatever their cause, could lead to aberrant immune responses to a viral infection (eg occurring during adolescence), which could be the proximate trigger of schizophrenia symptoms. Undoubtedly, animal models have been instrumental in elucidating mechanisms and consequences of cerebral lateralization under normal and pathological conditions, but the modulatory capacity of viruses in these processes has been relatively neglected.
Static vs progressive disease
One of the tenets of the neurodevelopmental hypothesis for schizophrenia is that once the developmental insult is complete and psychotic symptoms arise, the abnormalities in the brain are non-progressive. 2, 144 However, this statement deserves qualification because 'developmental' changes can span two decades-a typical latency period for the disease. 7, 145, 146 Therefore, the question remains: when do the well-described brain abnormalities (eg ventricular enlargement) arise in schizophrenia and do they progress during the latency period? The finding of ventriculomegaly in first episode schizophrenia patients suggests that brain abnormalities precede diagnosis, 147, 148 but the issue of whether these abnormalities progress has been contentious. Progressive ventricular enlargement has been measured during childhood schizophrenia, 149 and a convincing case can be made for a subtype of schizophrenia that has a progressive neurodegenerative course. 51, 132, 150, 151 A progressive vs static disease course may be determined by the particular etiologic agent or by genetic factors. Amid the controversy concerning neuropathological progression in schizophrenia, the role of perinatal viral infections has received little attention. Therefore, our group is currently using an animal model to examine potential mechanisms by which some individuals may succumb to progressive degeneration following a neonatal viral infection (see below).
Behavioral and neuropsychological
Recent years have seen considerable progress toward the goal of creating neurodevelopmental animal models that reproduce some of the key behavioral aspects of schizophrenia. 152 These models have utilized a number of manipulations to disrupt the developing brain including amphetamines, 153 neurotoxicants, [154] [155] [156] [157] [158] [159] hypoxia, 160 malnutrition, 161 surgical ablations, 162 and postnatal separation. 163 An advantage of animal models is that they allow behavioral abnormalities to be correlated with structural and neurochemical alteration as a function of developmental stage. For example, substantial insights have been gained from a model which exploits excitotoxic lesions of the developing ventral hippocampus. 152, 157, 158 This model is particularly promising because behavioral features analogous to schizophrenia arise after a maturational latency, and then are normalized by administration of antipsychotic drugs. iety of experimental prenatal or postnatal infections including herpes simplex I, 103, 164, 165 LCMV, [166] [167] [168] Borna disease virus, 105, 169, 170 and Vesicular stomatitis virus. 104 Although there is no lack of data demonstrating that prenatal infections can profoundly disturb adult behavior, there is a salient need to meld these findings with new experimental advances in modeling schizophrenia, and thus begin to examine the effects of antipsychotic medications on virus-induced behavioral disturbances.
Integrating viral and neurodevelopmental mechanisms: the role of animal models
Considering the dearth of knowledge as to how viruses can cause latent psychosis or pathology resembling schizophrenia, a variety of viruses with the ability to infect the developing brain could hold clues to the mechanisms of schizophrenia pathogenesis. Examples from studies focusing on LCMV in rats serve to illustrate the utility of animal models in addressing some of the controversies mentioned above including neuronal specificity, neurotransmitter alterations and mechanism of disease progression. In these studies we have focused on the hippocampal formation because its development is completed late in gestation, allowing for a subtle defect, 171 and the adult hippocampus is functionally well poised to mediate schizophrenia symptoms because it is pivotal to memory gating and sensory representations, and is interconnected with other brain regions associated with schizophrenia. 90, 91 Moreover, reduced hippocampal volume and lateral ventricular enlargement are among the most consistent neuroanatomical findings in the disease. 7, 89 To model abnormalities of hippocampal development, rats are infected intracranially with LCMV at 4 days old as originally described by Monjan et al. 167, [172] [173] [174] At this age, the developmental stage of the rat hippocampal dentate gyrus corresponds to the stage of the human dentate gyrus attained during the second trimester in utero; 171, 175 this is commonly thought to be the critical period for a neurodevelopmental insult to trigger schizophrenia. 8, 33 In these rats, LCMV shows stark specificity for which neurons it infects, including neuronal subsets in the hippocampus. [172] [173] [174] 176 By examining the consequences of this cell-type selective infection we endeavor to uncover clues to the genesis of hippocampal circuitry abnormalities in schizophrenia.
Although LCMV is non-cytopathic to neurons, the virus is capable of causing latent hippocampal abnormalities which appear to progress even after infectious virus is cleared. 174, 176 Hippocampal dentate granule cells and GABAergic interneurons are infected early in the disease. 173, 174 The dentate granule cells are mitotically active at the time of the infections, 175 and while GABAergic neurons are thought to cease dividing prenatally, they are undergoing the final stages of differentiation during this postnatal interval. 173, 177, 178 GABAergic neurons appear to become impaired because electrophysiological recordings in the dentate gyrus of adult rats, originally infected with LCMV as
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neonates, have demonstrated a marked defect in inhibitory neurotransmission. 172 Accordingly, immunohistochemistry has revealed a decrease in a subset of GABAergic cells (those expressing parvalbumin). 172 As the rats proceed toward sexual maturity, degeneration of dentate granule cells becomes apparent, 167, 172, 179 and the adults manifest varying degrees of hippocampal volume reduction and lateral ventricular dilation. Thus neonatal LCMV infection appears to cause disinhibition of principle cells within the hippocampal dentate gyrus, and this deficient inhibitory control could trigger a pathophysiological cascade in which glutamatergic input is released from its inhibitory control thus leading to the latent death of dentate granule cells as a consequence of synaptically-mediated excitotoxicity. 172, 173 Other viruses which also target the hippocampus could lead to analogous alterations in the balance between inhibition and excitation. 43 
Virus induced disinhibition and excitotoxicity
Although there is no evidence that LCMV is the cause of schizophrenia, this model has provided preliminary evidence for a hypothesis that could clarify some of the pathophysiological enigmas outlined in the previous section. Specifically, it is proposed that some cases of schizophrenia could be due to 'Virus-Induced Disinhibition and Excitotoxicity' (VIDE). The VIDE mechanism invokes a specific pathophysiological connection between a perinatal viral infection and the terminal neuropathological features of the schizophrenia. Specifically, a viral infection of the developing pre-schizophrenic brain is posited to occur during cellular differentiation of corticohippocampal GABAergic interneurons. Assuming the causative virus is noncytopathic like LCMV, infected GABAergic interneurons would survive the initial infection while still undergoing disruption of non-essential (luxury) cell functions-the ability of non-cytopathic viruses to perturb neuronal luxury functions such as neurotransmitter production and synaptogensis is well established, and the possibility that differentiating GABAergic neurons are vulnerable to such disruption is implied by our data in LCMV-infected rats. 173, 180 Early impairment of inhibitory neurotransmission might then give rise to motor and cognitive disturbances which often presage schizophrenia. 1 The VIDE mechanism implies variable disease progression depending on compensatory processes, and more importantly, redundancy or reserve of GABAergic innervation or parallel inhibitory circuits. For example, an individual with highly redundant GABAergic innervation might only manifest schizotypal symptoms without further progression, while a patient with minimal redundancy could become psychotic prior to adolescence. Besides psychosocial factors, a suggested precipitant of initial schizophrenic episodes is the maturation of fiber tracts such as the superficial medullary lamina during adolescence. 91 This latedeveloping trigger is consistent with a VIDE mechanism since presumably these tracts likely carry excit-atory inputs to the already disinhibited principle cells. A neurodegenerative course in a subset of patients with minimal reserve is likewise predicted by VIDE since unchecked excitatory input is expected to eventually cause the excitotoxic death of principle cells. Correspondingly, a decrease in glutamate markers in some patients at end stage disease is also explained by VIDE because most principle cells (eg dentate granule cells, pyramidal neurons) in brain regions associated with schizophrenia are excitatory and contain glutamate, 125 and their death would be reflected as a glutamatergic deficit. Thus it is important to determine how much of the brain atrophy in schizophrenia can be attributed to loss of excitatory neurons or axons, and further to define the quantitative relationship between such loss and CSF glutamate levels. This may not be a simple task given that neuroleptic drugs may prop up GABAergic neurotransmission, and hence could be neuroprotective. 181, 182 In any case, VIDE is a speculative but intriguing and testable mechanism that could provide a viral nexus to the prevailing neurodevelopmental theory of schizophrenia.
Conclusions
Huge challenges lie ahead in defining the pathogenesis of schizophrenia and the relative contribution of viral infections. Despite contemporary acceptance that schizophrenia is a brain disorder, this realization provides only an incremental advance toward the goal of building a comprehensive theory that integrates genetic, neurodevelopmental, environmental, immune, and neuropsychological features of the disease. A step toward this goal is recognizing that schizophrenia is likely a heterogeneous disorder and its clinical subtypes may be manifestations of a disparate pathophysiological mechanism. Accordingly, viral infections during development may engender only a portion of the multiple disease subtypes that are subsumed under the rubric of schizophrenia. Conversely, a viral infection could give rise to multiple disease subtypes depending on the timing of the infection and host factors such as immunogenetics, prior pathogen exposure, and neurocircuitry reserve. In any case, exploring these possibilities is facilitated by model systems which point to testable hypotheses.
